Joanne McCarthy

Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial

P. Phiri, S. Rathod, H. Price, 2019, Trials.

The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: Results of a pilot randomized, double‐blind, placebo‐controlled trial

P. Phiri, S. Rathod, R. Holt, 2021, Diabetes, obesity & metabolism.

Feasibility and acceptability of transcranial stimulation in obsessive–compulsive symptoms (FEATSOCS): study protocol for a randomised controlled trial of transcranial direct current stimulation (tDCS) in obsessive–compulsive disorder (OCD)

N. Fineberg, Kabir Garg, E. Cinosi, 2021, Pilot and Feasibility Studies.